Treatment emergent number of Adverse Events;Area Under the Plasma Concentration Time Curve from predose until last detectable concentration of niclosamide(AUC0-last) of niclosamide [µg/ml*h];Maximum plasma concentration of niclosamide (µg/ml)

Treatment emergent number of Adverse Events;Area Under the Plasma Concentration Time Curve from predose until last detectable concentration of niclosamide(AUC0-last) of niclosamide [µg/ml*h];Maximum plasma concentration of niclosamide (µg/ml)